the efficacy and safety of betamethasone dipropionate , 0.05 % in a propylene glycol base ( diprolene ) , was investigated in an open , fixed-dose study of thirty-one patients with resistant psoriasis .
C0053523
betamethasone dipropionate
C0033860
psoriasis